✦ LIBER ✦

P-942 Iressa in patients with advanced non-small cell lung cancer(NSCLC) progressed to chemotherapy. Spain expanded acces program (EAP)

✍ Scribed by Castellano, D.; Neciosup, S.; Velasco, A.; Masutti, B.; Gomez, C.; Moyano, A.; Constenla, M.; Lopez-Brea, M.; Diz Taín, P.; Cortes-Funes, H.

Book ID: 122984594
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 152 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(05)81435-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

825 Statistical analysis of survival in

825 Statistical analysis of survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib (‘Iressa’, ZD1839) in an expanded access program (EAP): preliminary results

✍ M. Wolf; D. Farina-Sisofo; J. Grous; G. Kennealey; J. Ochs 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 166 KB

P-583 Clinical parameters predictive of

P-583 Clinical parameters predictive of response in advance non-small-cell lung cancer (NSCLC) patients receiving gefitinib in am expanded access program (EAP) after failure of chemotherapy

✍ Tibaldi, C.; Vasile, E.; Chella, A.; Russo, E.; Bernardini, I.; Nacci, A.; Falco 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 293 KB

P-587 Experience from a large multi-cent

P-587 Experience from a large multi-centre expanded access programme (EAP) with gefitinib (‘Iressa’, ZD1839) as monotherapy in advanced non-small cell lung cancer (NSCLC)

✍ van Puijenbroek, R.; Bosquée, L.; Tits, G.; Germonpre, P.; Strobbe, E.; Vansteen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 294 KB

An expanded access program of erlotinib

An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): Data report from Italy

✍ Tiseo, Marcello; Gridelli, Cesare; Cascinu, Stefano; Crinò, Lucio; Piantedosi, F 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 541 KB

P-491 Palliative chemotherapy (QT) and p

P-491 Palliative chemotherapy (QT) and prognostic factors in elderly patients with advanced non-small Cell lung cancer (NSCLC)

✍ Guerreroero Zotano, A.; Pellin Ariño, L.; Molina Saera, J.; Palomar Abad, L.; Po 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 285 KB

Prognostic factors for response to plati

Prognostic factors for response to platinum-based chemotherapy programs in patients with unresectable non small cell lung cancer (NSCLC)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 144 KB